All human beings—regardless of age, sex, race or income—are equal in dignity and rights. Yet 222 million women in developing countries are unable to exercise the human right to voluntary family planning.
This flagship report analyzes data and trends to understand who is denied access and why. It examines challenges in expanding access to family planning. And it considers the social and economic impact of family planning as well as the costs and savings of making it available to everyone who needs it.
The report asserts that governments, civil society, health providers and communities have the responsibility to protect the right to family planning for women across the spectrum, including those who are young or unmarried.
Male and female condoms are currently the only effective dual protection methods against unintended pregnancy and the transmission of STIs and HIV. In recent years, an important development has been the emergence of new FC products, differing in design and materials, that have the potential to lower cost, improve acceptability and increase choice and options for couples who choose to use FCs as their prevention method. The purpose of this meeting was to develop strategies, recommendations and guidelines for future female condom (FC) parallel programming. This meeting presented an update on FC product technology, shared experiences and plans for FC programming and reviewed current FC programmes and initiatives that will support FC programming more broadly.
This report presents new 2012 estimates of the numbers and proportions of women in the developing world using modern methods and in need of modern contraception, as well as the cost and impact of meeting this need. The 2012 Adding It Up estimates are comparable to those from the 2009 report and will therefore enable us to assess progress between 2008 and 2012. The estimates presented here incorporate the most recent available survey data on need for and use of contraception and updated 2012 estimates of the direct costs of providing contraceptive services. They also draw on updated estimates of pregnancies and maternal deaths.
Programmatic and research considerations for hormonal contraception for women at risk of HIV and women living with HIV
Between 31 January and 2 February 2012, the World Health Organization (WHO) convened a meeting of experts to discuss recent research on use of hormonal contraception by women at high risk of HIV and those currently living with HIV and its implications. The Technical Consultation brought together 75 participants from 18 countries; 18 agencies were represented. The multidisciplinary group comprised experts in international family planning and HIV, including clinicians, epidemiologists, researchers, programme managers, policy-makers, guideline methodologists, reproductive biologists and pharmacologists, HIV advocates, and women’s health advocates.
Women worldwide have been forced or coerced by medical personnel to submit to permanent and irreversible sterilization procedures. Despite condemnation from the United Nations, cases of forced and coerced sterilization have been reported in North and South America, Africa, Asia, and Europe. Women who are poor or stigmatized are most likely to be deemed “unworthy” of reproduction. Perpetrators are seldomly held accountable and victims rarely obtain justice for this violent abuse of their rights.
Marion Stevens, treatment monitor with the Health Systems Trust, reflects on adolescent sexual and reproductive healthcare during Youth Month.With June being Youth Month, it's important to consider and reflect on the area of adolescent sexual and reproductive healthcare. This is an area that is often ignored as we grapple with the reality that adolescents are choosing tobe sexually active, but cultural practices often limit open communication about sex with our cllildren. As nurses we have a responsibility to provide care of adolescents' sexual health, which also includes the results of unplanned pregnancies,abortion, spread of sexually transmitted infections (STIs) including HIV and maternal mortality and morbidity.